Expression of angiopoietin-Like 3 associated with puromycin-induced podocyte damage

Nephron - Experimental Nephrology

Volumn 115, Issue 3, 2010, Pages

  Jia, Rao ^a   Hong, Xu ^a   Li, Sun ^a   Haichun, Yang ^b   Chuanming, Hao ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Agrin; Angiopoietin like 3; Perlecan; Podocyte; Puromycin

Indexed keywords

AGRIN; ANGIOPOIETIN; ANGIOPOIETIN 3; DNA; PERLECAN; PUROMYCIN; UNCLASSIFIED DRUG; ANGPTL3 PROTEIN, MOUSE; PROTEOHEPARAN SULFATE; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CELL ADHESION; CELL DAMAGE; DOWN REGULATION; GENETIC TRANSFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ACUTE KIDNEY FAILURE; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; METABOLISM;

AGRIN; ANGIOPOIETINS; ANIMALS; CELL ADHESION; HEPARAN SULFATE PROTEOGLYCANS; KIDNEY FAILURE, ACUTE; MICE; PODOCYTES; PUROMYCIN AMINONUCLEOSIDE; TRANSFECTION; ACUTE KIDNEY INJURY;

EID: 77951251616     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313829     Document Type: Article

References (16)

1. Shimizugawa T, Ono M, Shimamura M, et al: ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem 2002; 277: 33742-33748.
2. Ando Y, Shimizugawa T, Takeshita S, et al: A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoEdeficient mice. J Lipid Res 2003; 44: 1216-1223.
3. Koster A, Chao YB, Mosior M, et al: Transgenic angiopoietin-like (ANGPTL)4 overexpression and targeted disruption of ANGPTL4 and ANGPTL3: regulation of triglyceride metabolism. Endocrinology 2005; 146: 4943-4950.
4. Camenisch G, Pisabarro MT, Sherman D, et al: ANGPTL3 stimulates endothelial cell adhesion and migration via integrinα vβ3 and induces blood vessel formation in vivo. J Biol Chem 2002; 277: 17281-17290.
5. Xu Y, Liu YJ, Yu Q: Angiopoietin-3 is tethered on the cell surface via heparan sulfate proteoglycans. J Biol Chem 2004; 279: 41179-41188.
6. Cazes A, Galaup A, Chomel C, Bignon M, et al: Extracellular matrix-bound angiopoietin- like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 2006; 99: 1207-1215.
7. Shimamura M, Matsuda M, Kobayashi S, et al: Angiopoietin like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes. Biochem Biophys Res 2003; 301: 601-609.
8. Wu Jianwen, Xu Hong, Wu Ying, et al: Expression of ANGPTL3 in kidney and its relationship to proteinuria and hyperlipidemia in Adriamycin-induced nephrotic rats. Chinese Journal of Nephrology 2005; 21: 207-212.
9. Martin PT, Sanes JR: Integrins mediate adhesion to agrin and modulate agrin signaling. Development 1997; 124: 3909-3917.
10. Ha TS, Song CJ, Lee JH: Effect of advanced glycosylation end products on perlecan core protein of glomerular epithelium. Pediatr Nephrol 2004; 19: 1219-1224.
11. O'Toole JJ, Deyst KA, Bowe MA, et al: Alternative splicing of agrin regulates its binding to heparin α-dystroglycan, and the cell surface. Proc Natl Acad Sci USA 1996; 93: 7369-7374.
12. Battaglia C, Mayer U, Aumailley M, et al: Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and nidogen by sites in the protein core. Eur J Biochem 1992; 208: 359-366.
13. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstadt H, Davidson GR, Kriz W, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248-258.
14. Reiser J, Oh J, Shirato I, et al: Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and 3 integrin. J Biol Chem 2004;279: 34827-34832.
15. Vega-Warner V, Ransom RF, Vincent AM, et al: Induction of antioxidant enzyme in murine podocytes precedes injury by PAN aminonucleoside. Kidney Int 2004;66: 1881-1889.
16. Teixeira V de P, Blattner SM, Li M, et al: Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005; 67: 514-523.